OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A Working Hypothesis Regarding Identical Pathomechanisms between Clinical Efficacy and Adverse Reaction of Clozapine via the Activation of Connexin43
Motohiro Okada, Kouji Fukuyama, Takashi Shiroyama, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 19, pp. 7019-7019
Open Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

Connexin 43: An Interface Connecting Neuroinflammation to Depression
Hong Jiang, Yi Zhang, Zhen‐Zhen Wang, et al.
Molecules (2023) Vol. 28, Iss. 4, pp. 1820-1820
Open Access | Times Cited: 19

Connexin 43 Phosphorylation: Implications in Multiple Diseases
Meng Zhang, Zhen‐Zhen Wang, Nai‐Hong Chen
Molecules (2023) Vol. 28, Iss. 13, pp. 4914-4914
Open Access | Times Cited: 19

Astroglial Connexin 43-Mediated Gap Junctions and Hemichannels: Potential Antidepressant Mechanisms and the Link to Neuroinflammation
Lan Lei, Y Wang, Die Hu, et al.
Cellular and Molecular Neurobiology (2023) Vol. 43, Iss. 8, pp. 4023-4040
Closed Access | Times Cited: 16

Current Limitations and Candidate Potential of 5-HT7 Receptor Antagonism in Psychiatric Pharmacotherapy
Ruri Okubo, Toshiki Hasegawa, Kouji Fukuyama, et al.
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 39

Therapeutic Potential and Limitation of Serotonin Type 7 Receptor Modulation
Kouji Fukuyama, Eishi Motomura, Motohiro Okada
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2070-2070
Open Access | Times Cited: 15

Dysfunction of the NMDA Receptor in the Pathophysiology of Schizophrenia and/or the Pathomechanisms of Treatment-Resistant Schizophrenia
Ruri Okubo, Motohiro Okada, Eishi Motomura
Biomolecules (2024) Vol. 14, Iss. 9, pp. 1128-1128
Open Access | Times Cited: 4

Effects of Subchronic Administrations of Vortioxetine, Lurasidone, and Escitalopram on Thalamocortical Glutamatergic Transmission Associated with Serotonin 5-HT7 Receptor
Motohiro Okada, Ryusuke Matsumoto, Yoshimasa Yamamoto, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 3, pp. 1351-1351
Open Access | Times Cited: 29

Connexin 43: insights into candidate pathological mechanisms of depression and its implications in antidepressant therapy
Ningning Zhang, Yi Zhang, Zhen‐Zhen Wang, et al.
Acta Pharmacologica Sinica (2022) Vol. 43, Iss. 10, pp. 2448-2461
Open Access | Times Cited: 21

Astroglial Connexin43 as a Potential Target for a Mood Stabiliser
Motohiro Okada, Tomoka Oka, Misaki Nakamoto, et al.
International Journal of Molecular Sciences (2020) Vol. 22, Iss. 1, pp. 339-339
Open Access | Times Cited: 30

Can rodent models elucidate the pathomechanisms of genetic epilepsy?
Motohiro Okada
British Journal of Pharmacology (2021) Vol. 179, Iss. 8, pp. 1620-1639
Open Access | Times Cited: 26

Unveiling the hidden pathways: Exploring astrocytes as a key target for depression therapy
Ying Liu, Lu Chen, Lin Lin, et al.
Journal of Psychiatric Research (2024) Vol. 174, pp. 101-113
Closed Access | Times Cited: 3

Impacts of exposure to and subsequent discontinuation of clozapine on tripartite synaptic transmission
Motohiro Okada, Kouji Fukuyama, Eishi Motomura
British Journal of Pharmacology (2024) Vol. 181, Iss. 22, pp. 4571-4592
Open Access | Times Cited: 3

Candidate Strategies for Development of a Rapid-Acting Antidepressant Class That Does Not Result in Neuropsychiatric Adverse Effects: Prevention of Ketamine-Induced Neuropsychiatric Adverse Reactions
Motohiro Okada, Yasuhiro Kawano, Kouji Fukuyama, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 21, pp. 7951-7951
Open Access | Times Cited: 25

Age-Dependent and Sleep/Seizure-Induced Pathomechanisms of Autosomal Dominant Sleep-Related Hypermotor Epilepsy
Kouji Fukuyama, Motohiro Okada
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 21, pp. 8142-8142
Open Access | Times Cited: 24

Effects of Atypical Antipsychotics, Clozapine, Quetiapine and Brexpiprazole on Astroglial Transmission Associated with Connexin43
Kouji Fukuyama, Motohiro Okada
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 11, pp. 5623-5623
Open Access | Times Cited: 20

Brivaracetam prevents astroglial l-glutamate release associated with hemichannel through modulation of synaptic vesicle protein
Motohiro Okada, Kouji Fukuyama, Takashi Shiroyama, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 138, pp. 111462-111462
Open Access | Times Cited: 19

Pharmacovigilance in Action: Utilizing VigiBase Data to Improve Clozapine Safety
Carlos De las Cuevas, Emílio J. Sanz, José de León
Patient Preference and Adherence (2024) Vol. Volume 18, pp. 2261-2280
Open Access | Times Cited: 2

Clozapine Worsens Glucose Intolerance, Nonalcoholic Fatty Liver Disease, Kidney Damage, and Retinal Injury and Increases Renal Reactive Oxygen Species Production and Chromium Loss in Obese Mice
Geng‐Ruei Chang, Hsien-Yueh Liu, Wei‐Cheng Yang, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 13, pp. 6680-6680
Open Access | Times Cited: 17

Impact of 5-HT7 receptor inverse agonism of lurasidone on monoaminergic tripartite synaptic transmission and pathophysiology of lower risk of weight gain
Kouji Fukuyama, Eishi Motomura, Takashi Shiroyama, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 148, pp. 112750-112750
Open Access | Times Cited: 12

Brivaracetam and Levetiracetam Suppress Astroglial L-Glutamate Release through Hemichannel via Inhibition of Synaptic Vesicle Protein
Kouji Fukuyama, Motohiro Okada
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 9, pp. 4473-4473
Open Access | Times Cited: 12

Dose-Dependent Biphasic Action of Quetiapine on AMPK Signalling via 5-HT7 Receptor: Exploring Pathophysiology of Clinical and Adverse Effects of Quetiapine
Motohiro Okada, Kouji Fukuyama, Eishi Motomura
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 16, pp. 9103-9103
Open Access | Times Cited: 11

Chronic Administrations of Guanfacine on Mesocortical Catecholaminergic and Thalamocortical Glutamatergic Transmissions
Kouji Fukuyama, Tomosuke Nakano, Takashi Shiroyama, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 8, pp. 4122-4122
Open Access | Times Cited: 15

Distinct Effects of Escitalopram and Vortioxetine on Astroglial L-Glutamate Release Associated with Connexin43
Takashi Shiroyama, Kouji Fukuyama, Motohiro Okada
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 18, pp. 10013-10013
Open Access | Times Cited: 13

Brexpiprazole Reduces 5-HT7 Receptor Function on Astroglial Transmission Systems
Kouji Fukuyama, Eishi Motomura, Motohiro Okada
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 12, pp. 6571-6571
Open Access | Times Cited: 9

A Novel Gliotransmitter, L-β-Aminoisobutyric Acid, Contributes to Pathophysiology of Clinical Efficacies and Adverse Reactions of Clozapine
Kouji Fukuyama, Eishi Motomura, Motohiro Okada
Biomolecules (2023) Vol. 13, Iss. 9, pp. 1288-1288
Open Access | Times Cited: 5

Page 1 - Next Page

Scroll to top